We are live on ! Find out more
TYCC

Texas Yale Capital Corp Portfolio holdings

AUM $3.52B
1-Year Est. Return 52.63%
This Fund
S&P 500
This Quarter Est. Return
+9.05%
1 Year Est. Return
+52.63%
3 Year Est. Return
+137.29%
5 Year Est. Return
+205.78%
10 Year Est. Return
+676.18%
AUM
$1.75B
AUM Growth
+$158M
Cap. Flow
+$22M
Cap. Flow %
1.26%
Top 10 Hldgs %
41.77%
Holding
478
New
39
Increased
138
Reduced
46
Closed
11

Sector Composition

Rank Sector Weight
1 Technology 34.18%
2 Financials 10.59%
3 Consumer Discretionary 6.71%
4 Energy 6.52%
5 Industrials 6.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAMMU
451
DELISTED
Aries I Acquisition Corporation Unit
RAMMU
$100K 0.01%
+10,000
New +$100K
ATMR.U
452
DELISTED
Altimar Acquisition Corp II Units
ATMR.U
$100K 0.01%
+10,000
New +$101K
SVFA
453
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
$99K 0.01%
+10,000
New +$101K
CPUH
454
DELISTED
Compute Health Acquisition Corp.
CPUH
$98K 0.01%
+10,000
New +$98.2K
PSLV icon
455
Sprott Physical Silver Trust
PSLV
$13.2B
$96K 0.01%
10,385
+275
+3% +$2.63K
LOGC
456
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$89K 0.01%
20,000
+10,000
+100% +$50.9K
TELL
457
DELISTED
Tellurian Inc.
TELL
$88K 0.01%
+18,921
New +$58K
ARLP icon
458
Alliance Resource Partners
ARLP
$3.17B
$84K ﹤0.01%
11,677
NNDM
459
Nano Dimension
NNDM
$343M
$82K ﹤0.01%
10,000
GOSS icon
460
Gossamer Bio
GOSS
$87M
$81K ﹤0.01%
+10,000
New +$86.7K
SNDL icon
461
Sundial Growers
SNDL
$320M
$76K ﹤0.01%
8,000
KLDO
462
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$74K ﹤0.01%
+10,000
New +$70.9K
QTTB icon
463
Q32 Bio
QTTB
$464M
$73K ﹤0.01%
556
CENN icon
464
Cenntro
CENN
$8.43M
$72K ﹤0.01%
+12
New +$67.8K
DFTX
465
Definium Therapeutics
DFTX
$6.12B
$60K ﹤0.01%
+1,153
New +$60.5K
DEH.WS
466
DELISTED
D8 Holdings Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exer
DEH.WS
$33K ﹤0.01%
+20,000
New +$26.3K
ATMR.WS
467
DELISTED
Altimar Acquisition Corp II Warrants
ATMR.WS
$13K ﹤0.01%
+11,390
New +$11.7K
ECH icon
468
iShares MSCI Chile ETF
ECH
$1.06B
-6,514
Closed -$223K
HON icon
469
Honeywell
HON
$78B
-1,116
Closed -$228K
SEDG icon
470
SolarEdge
SEDG
$1.95B
-973
Closed -$280K
CPUH.U
471
DELISTED
Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant
CPUH.U
-10,000
Closed -$101K
SVFAU
472
DELISTED
SVF Investment Corp. Unit
SVFAU
-10,000
Closed -$106K
COLIU
473
DELISTED
Colicity Inc. Units
COLIU
-20,000
Closed -$202K
NDACU
474
DELISTED
NightDragon Acquisition Corp. SCALE Units
NDACU
-20,000
Closed -$204K
LMACU
475
DELISTED
Liberty Media Acquisition Corporation Unit
LMACU
-25,000
Closed -$268K

Similar funds

Texas Yale Capital Corp's Q2 2021 Portfolio in Review

As of Q2 2021, Texas Yale Capital Corp held 478 positions worth $1.75B, up 9.9% from $1.59B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Texas Yale Capital Corp's Q2 2021 filing shows 39 new, 138 increased, 46 reduced and 11 closed positions. Its largest new stake was Vanguard Ultra-Short Bond ETF: 18,520 shares worth $928K. The largest sale was Varian Medical Systems, Inc., an estimated $2.24M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 34% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Texas Yale Capital Corp's largest Q2 2021 buy was Vanguard Ultra-Short Bond ETF: 18,520 shares worth $928K.
  • Texas Yale Capital Corp added most to PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q2 2021, an estimated $3.08M increase.
  • Texas Yale Capital Corp's biggest Q2 2021 reduction was Apple, cutting an estimated $1.27M.
  • Texas Yale Capital Corp fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $2.24M.
  • Texas Yale Capital Corp's ten largest holdings make up 42% of its $1.75B portfolio in Q2 2021.
  • Texas Yale Capital Corp opened 39 new positions and closed 11 in Q2 2021.
  • Texas Yale Capital Corp's portfolio value rose 9.9% quarter-over-quarter to $1.75B.

Based on Texas Yale Capital Corp's 13F filing for Q2 2021, filed 5 Aug 2021.